| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.7M | -23.0% |
| SG&A Expense | $10.7M | -1.6% |
| Operating Income | -$21.4M | +13.6% |
| Pre-tax Income | -$17.2M | +29.2% |
| Net Income | -$17.2M | +29.2% |
| EPS (Basic) | -$0.40 | +39.4% |
| EPS (Diluted) | -$0.40 | +39.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | +68.4% |
| Short-term Investments | $2.2M | +0.0% |
| Current Assets | $1.9M | -38.9% |
| Total Assets | $4.2M | -50.2% |
| Current Liabilities | $7.8M | -11.4% |
| Total Liabilities | $9.1M | -20.9% |
| Stockholders' Equity | -$4.9M | -61.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.5M | -5.9% |
| Capital Expenditures | $18K | -37.9% |
| Investing Cash Flow | $2.2M | +119.7% |
| Financing Cash Flow | $19.0M | +7873.9% |
| Free Cash Flow | -$20.5M | -5.8% |